| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4878607
Max Phase: Preclinical
Molecular Formula: C26H38F6O4
Molecular Weight: 528.57
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OCCO)CC[C@@]43C)[C@@H]1CC[C@@H]2[C@H](O)CC(O)(C(F)(F)F)C(F)(F)F
Standard InChI: InChI=1S/C26H38F6O4/c1-22-9-7-16(36-12-11-33)13-15(22)3-4-17-18-5-6-20(23(18,2)10-8-19(17)22)21(34)14-24(35,25(27,28)29)26(30,31)32/h3,16-21,33-35H,4-14H2,1-2H3/t16-,17-,18-,19-,20+,21+,22-,23-/m0/s1
Standard InChI Key: JJYZJTJEAOPZOA-JIJMJNLVSA-N
Associated Targets(Human)
KMS-11 183 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 528.57 | Molecular Weight (Monoisotopic): 528.2674 | AlogP: 5.55 | #Rotatable Bonds: 6 |
| Polar Surface Area: 69.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
| #RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 7.91 | CX Basic pKa: | CX LogP: 4.23 | CX LogD: 4.12 |
| Aromatic Rings: 0 | Heavy Atoms: 36 | QED Weighted: 0.31 | Np Likeness Score: 1.68 |
References
| 1. Castelli R, Taranto S, Furiassi L, Bozza N, Marseglia G, Ferlenghi F, Rivara S, Retini M, Bedini A, Spadoni G, Matarazzo S, Ronca R, Presta M, Mor M, Giacomini A.. (2021) Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma., 221 [PMID:34004471] [10.1016/j.ejmech.2021.113529] |
Source
Source(1):